1. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism
   Sugarniya Subramaniam et al, 2019, Clinical Chemistry CrossRef
2. Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor
   Julia Ramírez-Moya et al, 2022, Scientific Reports CrossRef
3. Identification of epigenetic regulators in the estrogen signaling pathway via siRNA screening
   Yun Ren et al, 2021, Molecular Omics CrossRef
4. Prognostic and predictive biomarkers in breast cancer: Past, present and future
   Andrea Nicolini et al, 2018, Seminars in Cancer Biology CrossRef
5. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
   Jiang-hui Zeng et al, 2019, Journal of Translational Medicine CrossRef
6. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt/β-catenin pathway
   Zhenyan Liu et al, 2022, Biochemical and Biophysical Research Communications CrossRef
7. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
   Qian Zhou et al, 2018, Anti-Cancer Drugs CrossRef
8. Correlation between miR‑222 and uterine cancer and its prognostic value
   Xiujuan Nie et al, 2018, Oncology Letters CrossRef
9. Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions
   Fan Zhang et al, 2019, Oncology Letters CrossRef